These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1972752)

  • 1. Biochemical and radiohistochemical analyses of alpha-2 adrenergic receptors in the kindling model of epilepsy.
    Chen LS; Weingart JB; McNamara JO
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1272-7. PubMed ID: 1972752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-2 receptors mediate an endogenous noradrenergic suppression of kindling development.
    Gellman RL; Kallianos JA; McNamara JO
    J Pharmacol Exp Ther; 1987 Jun; 241(3):891-8. PubMed ID: 2885413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anatomical evidence for alpha-2 adrenoceptor heterogeneity: differential autoradiographic distributions of [3H]rauwolscine and [3H]idazoxan in rat brain.
    Boyajian CL; Loughlin SE; Leslie FM
    J Pharmacol Exp Ther; 1987 Jun; 241(3):1079-91. PubMed ID: 3037066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site.
    Michel MC; Brodde OE; Schnepel B; Behrendt J; Tschada R; Motulsky HJ; Insel PA
    Mol Pharmacol; 1989 Mar; 35(3):324-30. PubMed ID: 2564631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient elevation of amygdala alpha 2 adrenergic receptor binding sites during the early stages of amygdala kindling.
    Chen MJ; Vigil A; Savage DD; Weiss GK
    Epilepsy Res; 1990 Mar; 5(2):85-91. PubMed ID: 2158441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry.
    Neubig RR; Gantzos RD; Brasier RS
    Mol Pharmacol; 1985 Nov; 28(5):475-86. PubMed ID: 2865672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological evidence for alpha-2 adrenoceptor heterogeneity: differential binding properties of [3H]rauwolscine and [3H]idazoxan in rat brain.
    Boyajian CL; Leslie FM
    J Pharmacol Exp Ther; 1987 Jun; 241(3):1092-8. PubMed ID: 2885406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors.
    U'Prichard DC; Greenberg DA; Snyder SH
    Mol Pharmacol; 1977 May; 13(3):454-73. PubMed ID: 17827
    [No Abstract]   [Full Text] [Related]  

  • 9. p-[125I]iodoclonidine, a novel radiolabeled agonist for studying central alpha 2-adrenergic receptors.
    Baron BM; Siegel BW
    Mol Pharmacol; 1990 Sep; 38(3):348-56. PubMed ID: 1976227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tight agonist binding may prevent the correct interpretation of agonist competition binding curves for alpha 2-adrenergic receptors.
    Convents A; De Backer JP; Convents D; Vauquelin G
    Mol Pharmacol; 1987 Jul; 32(1):65-72. PubMed ID: 2885739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
    Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient elevation of locus coeruleus alpha 2-adrenergic receptor binding during the early stages of amygdala kindling.
    Jimenez-Rivera CA; Chen MJ; Vigil A; Savage DD; Weiss GK
    Brain Res; 1989 Apr; 485(2):363-70. PubMed ID: 2541868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does [3H]2-methoxy-idazoxan (RX 821002) detect more alpha-2-adrenoceptor agonist high-affinity sites than [3H]rauwolscine? A comparison of nine tissues and cell lines.
    Erdbrügger W; Raulf M; Otto T; Michel MC
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1287-94. PubMed ID: 7791100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alpha2 adrenoreceptor agonist clonidine suppresses evoked and spontaneous seizures, whereas the alpha2 adrenoreceptor antagonist idazoxan promotes seizures in amygdala-kindled kittens.
    Shouse MN; Scordato JC; Farber PR; de Lanerolle N
    Brain Res; 2007 Mar; 1137(1):58-68. PubMed ID: 17214976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease in locus coeruleus [3H]idazoxan binding site density in genetically epilepsy-prone (GEPR) rats.
    Razani-Boroujerdi S; Tso-Olivas DY; Hoffman TJ; Weiss GK; Savage DD
    Brain Res; 1993 Jan; 600(2):181-6. PubMed ID: 8094641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estradiol reduction of the agonist high affinity form of the alpha 2-adrenoceptor in the hypothalamus of female rats: identification as the alpha 2D subtype.
    Karkanias GB; Etgen AM
    Mol Pharmacol; 1994 Mar; 45(3):509-16. PubMed ID: 7908407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence implicating alpha-2 adrenergic receptors in the anticonvulsant action of intranigral muscimol.
    Platt K; Butler LS; Bonhaus DW; McNamara JO
    J Pharmacol Exp Ther; 1987 Jun; 241(3):751-4. PubMed ID: 3037068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonadrenergic [3H]idazoxan binding sites are physically distinct from alpha 2-adrenergic receptors.
    Michel MC; Regan JW; Gerhardt MA; Neubig RR; Insel PA; Motulsky HJ
    Mol Pharmacol; 1990 Jan; 37(1):65-8. PubMed ID: 2153910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential localization of alpha 2-adrenergic receptor subtypes in brain.
    Wamsley JK; Alburges ME; Hunt MA; Bylund DB
    Pharmacol Biochem Behav; 1992 Feb; 41(2):267-73. PubMed ID: 1349434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and distribution of alpha 2-adrenergic receptors in the human intestinal mucosa.
    Valet P; Senard JM; Devedjian JC; Planat V; Salomon R; Voisin T; Drean G; Couvineau A; Daviaud D; Denis C
    J Clin Invest; 1993 May; 91(5):2049-57. PubMed ID: 8098045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.